Table 1.
Baseline characteristics of patients with PAF and SAF.
| PAF (n = 930) | SAF (n = 1220) | pa | |
|---|---|---|---|
| Age (mean, years) | 74.5 ± 9.8 | 77.7 ± 9.5 | <0.0001 |
| Sex, M | 422 (45.4%) | 573 (47.0%) | |
| NIHSS (mean) | 8.0 ± 6.7 | 8.7 ± 6.8 | 0.026 |
| Diabetes mellitus | 181 (19.5%) | 301 (24.7%) | 0.004 |
| Hypertension | 709 (76.2%) | 978 (80.2%) | 0.026 |
| Hyperlipidaemia | 318 (34.2%) | 405 (33.2%) | |
| History stroke/TIA | 211 (22.7%) | 357 (29.3%) | 0.001 |
| Current smoker | 110 (11.8%) | 95 (7.8%) | |
| Alcoholism | 50 (5.4%) | 92 (7.5%) | |
| History congestive heart failure | 89 (9.6%) | 281 (23.0%) | <0.0001 |
| History myocardial infarction | 116 (12.5%) | 180 (14.8%) | |
| History peripheral artery disease | 71 (7.6%) | 111 (9.1%) | |
| Pacemaker | 39 (4.2%) | 111 (9.1%) | <0.0001 |
| Lesion size | |||
| Small | 350 (37.6%) | 471 (38.6%) | |
| Medium | 310 (33.3%) | 428 (35.1%) | |
| Large anterior | 173 (18.6%) | 225 (18.4%) | |
| Large posterior | 62 (6.7%) | 74 (6.1%) | |
| Leukoaraiosis | 465 (50.0%) | 632 (51.8%) | |
| OAC | 812 (87.3%) | 976 (80.0%) | <0.0001 |
| VKA | 220 (23.7%) | 346 (28.4%) | |
| NOAC | 592 (63.7%) | 630 (51.6%) | <0.0001 |
| CHA2DS2-VASc > 4 | 682 (73.3%) | 988 (81.0%) | <0.0001 |
| Atrial enlargementb | 510 (62.5%) | 739 (74.6%) | <0.0001 |
NIHSS: National Institutes of Health Stroke Scale; PAF: paroxysmal atrial fibrillation; SAF: sustained atrial fibrillation; TIA: transient ischaemic attack.
ap-Values are given only if < 0.05.
b1806 Patients with trans-thoracic echocardiogram performed.